Xiamen Mogengel Biotechnology Co., Ltd.

Xiamen, China mogengel.com

Overview

Xiamen Mogengel Biotechnology Co., Ltd. is a private biotechnology company based in China. The company focuses on developing novel therapeutics with a strong emphasis on cutting-edge biotechnological research and innovation.

Therapeutic areas

OncologyCardiovascularImmunology

API / Drug Master Files

Xiamen Mogengel Biotechnology Co., Ltd. holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • MOGENGEL MATRIX IPSC LEVEL & MOGENGEL MATRIX ORGANOID CULTUREActive2026-03-27

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Xiamen Mogengel Biotechnology Co., Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Related companies

Chemexpress Co., Ltd.
China
Dalian Lansen Detai Biopharmaceutical Co., Ltd.
China
Tasly Pharmaceutical Group Co., Ltd.
China
Yantai Rongchang Pharmaceutical Co., Ltd.
China
Zhejiang Hisun Pharmaceutical Co., Ltd.
China
24cedo S.A.
Argentina
3BMS Australia Pty Ltd
Australia
Angitia Biopharmaceuticals, Inc.
United States

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo